Literature DB >> 21732472

A spatial view of the CD8+ T-cell response: the case of HCV.

Vito Racanelli1, Patrizia Leone, Arash Grakoui.   

Abstract

In viral infections, a memory T-cell population comprises multiple subtypes of cells, distributed in diverse anatomic compartments and possibly re-circulating among them. Accordingly, memory T cells display distinct phenotypes and functions, depending on the nature of the infecting virus, the anatomic location of the infection, and the differences between the sites of active infection and T-cell collection. This paper explores the body compartments where virus-specific CD8(+) T cells have been found during chronic hepatitis C virus infection, describes the cells' memory qualities, and discusses how they are spatially regulated, in comparison with other human viral infections. Understanding the role of compartmentalization and diversity of HCV-specific memory T-cell subsets may be the key to developing effective immunotherapies.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21732472      PMCID: PMC3549591          DOI: 10.1002/rmv.702

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  78 in total

1.  Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers.

Authors:  Eugene V Ravkov; Christy M Myrick; John D Altman
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

Review 2.  Progressive differentiation and selection of the fittest in the immune response.

Authors:  Antonio Lanzavecchia; Federica Sallusto
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

3.  The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines.

Authors:  Laila E Gamadia; Ester M M van Leeuwen; Ester B M Remmerswaal; Si-La Yong; Sugianto Surachno; Pauline M E Wertheim-van Dillen; Ineke J M Ten Berge; René A W Van Lier
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

4.  Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes.

Authors:  L Musey; Y Ding; J Cao; J Lee; C Galloway; A Yuen; K R Jerome; M J McElrath
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses.

Authors:  Xiao-Song He; Kutubuddin Mahmood; Holden T Maecker; Tyson H Holmes; George W Kemble; Ann M Arvin; Harry B Greenberg
Journal:  J Infect Dis       Date:  2003-03-19       Impact factor: 5.226

7.  Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells.

Authors:  Michaela Lucas; Ana L Vargas-Cuero; Georg M Lauer; Eleanor Barnes; Christian B Willberg; Nasser Semmo; Bruce D Walker; Rodney Phillips; Paul Klenerman
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

8.  Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection.

Authors:  Daniele Accapezzato; Vittorio Francavilla; Marino Paroli; Marco Casciaro; Lucia Valeria Chircu; Agostino Cividini; Sergio Abrignani; Mario U Mondelli; Vincenzo Barnaba
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

9.  Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection.

Authors:  Barbara L Shacklett; Catherine A Cox; Máire F Quigley; Christophe Kreis; Neil H Stollman; Mark A Jacobson; Jan Andersson; Johan K Sandberg; Douglas F Nixon
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

10.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

View more
  5 in total

1.  Postnatal development of lung T lymphocytes in a porcine model.

Authors:  Angel J Balam-May; Carmen Ramírez-Estudillo; Gloria Lazo-Vázquez; Marco A Vega-López
Journal:  Lung       Date:  2014-07-17       Impact factor: 2.584

2.  Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).

Authors:  Michael J Fuller; Benoit Callendret; Baogong Zhu; Gordon J Freeman; Dana L Hasselschwert; William Satterfield; Arlene H Sharpe; Lynn B Dustin; Charles M Rice; Arash Grakoui; Rafi Ahmed; Christopher M Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

3.  Transcriptomic assay of CD8+ T cells in treatment-naïve HIV, HCV-mono-infected and HIV/HCV-co-infected Chinese.

Authors:  Jin Zhao; Lina Yi; Jing Lu; Zheng-Rong Yang; Ying Chen; Chenli Zheng; Dan Huang; Yu-Feng Li; Lin Chen; Jinquan Cheng; Hsiang-Fu Kung; Ming-Liang He
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

Review 4.  Viral Persistence and Chronicity in Hepatitis C Virus Infection: Role of T-Cell Apoptosis, Senescence and Exhaustion.

Authors:  Muttiah Barathan; Rosmawati Mohamed; Yean K Yong; Meganathan Kannan; Jamuna Vadivelu; Alireza Saeidi; Marie Larsson; Esaki Muthu Shankar
Journal:  Cells       Date:  2018-10-12       Impact factor: 6.600

5.  Dendritic cell maturation in HCV infection: altered regulation of MHC class I antigen processing-presenting machinery.

Authors:  Patrizia Leone; Mariangela Di Tacchio; Simona Berardi; Teresa Santantonio; Massimo Fasano; Soldano Ferrone; Angelo Vacca; Franco Dammacco; Vito Racanelli
Journal:  J Hepatol       Date:  2014-04-13       Impact factor: 25.083

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.